Home » Quidel Posts 21 Percent Revenue Growth for Q4

Quidel Posts 21 Percent Revenue Growth for Q4

Mar 01, 2012

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Quidel reported after the close of the market Wednesday that its fourth-quarter revenues increased 21 percent year over year driven by its infectious disease and women's health products.

The San Diego-based diagnostics firm generated total revenues of $38.4 million for the three-month period ended Dec. 31, 2011, compared to $31.7 million for Q4 2010.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Scan

Prize for Five

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Sure, Blame the Test

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

This Week in Genome Research

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Low Down Syndrome Rates in Iceland

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.

What's Popular?

In PCR

  1. Curetis Posts 9 Percent Drop in H1 Revenues

  2. Single-Color Digital PCR Method Shows Promise for Blood-Based Cancer Monitoring

    Premium

  3. FDA Clears iCubate System, Bloodstream Infection Assay

  4. Biofortuna to Further Commercialize Genotyping Assays With £1.6M Financing

  5. FDA Grants EUA for Columbia University's Zika Test

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.